反应性单相狼疮肾炎:患病率、相关因素与结局
这项回顾性研究纳入374例狼疮肾炎患者,25.7%表现为反应性单相病程,与发病年龄较大和SLE病程较短相关;该病程中18.8%患者仍出现不良复合结局。
要点
- 374例LN患者中25.7%呈反应性单相病程,中位随访10.6年。
- 发病年龄较大(OR 1.04)和SLE病程较短(OR 0.91)与该病程相关。
- 反应性单相病程者中18.8%仍发生不良长期事件。
核心结论
- 约26%的LN患者表现为反应性单相病程,但预测该病程仍具挑战性。
- 尽管结局改善,18.8%的反应性单相病程患者仍发生不良长期事件。
研究设计与样本
- 回顾性研究,纳入观察性队列中在入组时或之后发生LN的SLE患者374例。
- 反应性单相病程定义为:亚肾病范围蛋白尿1年内或肾病范围蛋白尿2年内完全恢复,且此后无肾脏复发。
主要发现
- 374例LN患者(平均年龄32.8岁,89.2%女性,中位随访10.6年)中96例(25.7%)表现为反应性单相病程。
- 反应性单相病程与LN发病时年龄较大相关(OR 1.04,95%CI 1.01-1.07)。
- 反应性单相病程与LN发病时SLE病程较短相关(OR 0.91,95%CI 0.86-0.97)。
- Cox模型显示,蛋白尿及时恢复及此后无LN复发与不良复合结局风险降低相关。
- 反应性单相病程患者中18.8%仍发生不良事件。
关键数值与推荐
- 反应性单相病程定义:亚肾病范围蛋白尿1年内或肾病范围蛋白尿2年内完全恢复,且此后无肾脏复发。
- 不良复合结局包括终末期肾病、估算肾小球滤过率(eGFR)持续下降≥30%或死亡。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: LN is associated with significant renal morbidity, although some patients may experience a responsive and monophasic course. We aimed to assess the proportion of LN patients with such a course and identify its associated baseline characteristics. METHODS: This retrospective study included SLE patients from an observational cohort who developed LN at or after clinic entry. A responsive and monophasic course was defined as complete proteinuria recovery within 1 year for subnephrotic- or 2 years for nephrotic-range proteinuria, without subsequent renal flares. Univariable and multivariable logistic regression were used to assess the impact of baseline characteristics on developing a responsive and monophasic course, while Cox regression was used to explore the association with a long-term adverse composite outcome, including end-stage kidney disease, sustained ≥30% estimated glomerular filtration rate (eGFR) decline, or death. RESULTS: Among 374 LN patients (mean age: 32.8 years; 89.2% female; median follow-up: 10.6 years), 96 patients (25.7%) exhibited a responsive and monophasic course, which was associated with older age [odds ratio (OR) 1.04, 95% CI 1.01-1.07] and shorter SLE duration (OR 0.91, 95% CI 0.86-0.97) at LN onset. In the Cox model, timely recovery of proteinuria and the absence of subsequent LN flares were associated with a reduced risk of the adverse composite outcome. Despite these associations, 18.8% of patients with a responsive and monophasic course still experienced adverse events. CONCLUSION: Approximately 26% of LN patients exhibit a responsive and monophasic course. Predicting such a course remains challenging; despite improved outcomes, 18.8% of these patients still experience adverse long-term events.
引用
- Kharouf F, Mehta P, Carrizo Abarza V, et al. Responsive and monophasic lupus nephritis: prevalence, associations and outcomes. Rheumatology (Oxford). 2025. PMID: 40198238. doi:10.1093/rheumatology/keaf187
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。